Global Assets Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History

Global Assets Advisory's VRTX Position: Q2 2026 in Review

Global Assets Advisory increased its Vertex Pharmaceuticals (VRTX) stake by 14% in Q2 2026, buying an estimated $111K and bringing the position to 2,030 shares worth $1.01M. The position accounts for 0.22% of the portfolio, ranked #110.

Global Assets Advisory first reported a position in VRTX in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.25M in Q1 2025. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

• Global Assets Advisory held 2,030 shares of Vertex Pharmaceuticals worth $1.01M as of Q2 2026.
• Global Assets Advisory bought 250 Vertex Pharmaceuticals shares in Q2 2026, an estimated $111K.
• Vertex Pharmaceuticals made up 0.22% of Global Assets Advisory's portfolio in Q2 2026, its #110 holding.
• Global Assets Advisory first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
• Global Assets Advisory's Vertex Pharmaceuticals position peaked at $1.25M in Q1 2025.
• 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Global Assets Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.